These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 34099591)
1. S100A8 and S100A9, both transcriptionally regulated by PU.1, promote epithelial-mesenchymal transformation (EMT) and invasive growth of dermal keratinocytes during scar formation post burn. Xu Z; Cheng C; Kong R; Liu Y; Wang S; Ma Y; Xing X Aging (Albany NY); 2021 Jun; 13(11):15523-15537. PubMed ID: 34099591 [TBL] [Abstract][Full Text] [Related]
2. S100A9 has a protective role in inflammation-induced skin carcinogenesis. McNeill E; Hogg N Int J Cancer; 2014 Aug; 135(4):798-808. PubMed ID: 24436096 [TBL] [Abstract][Full Text] [Related]
3. The antimicrobial heterodimer S100A8/S100A9 (calprotectin) is upregulated by bacterial flagellin in human epidermal keratinocytes. Abtin A; Eckhart L; Gläser R; Gmeiner R; Mildner M; Tschachler E J Invest Dermatol; 2010 Oct; 130(10):2423-30. PubMed ID: 20555353 [TBL] [Abstract][Full Text] [Related]
4. S100A8 and S100A9 are messengers in the crosstalk between epidermis and dermis modulating a psoriatic milieu in human skin. Lee Y; Jang S; Min JK; Lee K; Sohn KC; Lim JS; Im M; Lee HE; Seo YJ; Kim CD; Lee JH Biochem Biophys Res Commun; 2012 Jul; 423(4):647-53. PubMed ID: 22683330 [TBL] [Abstract][Full Text] [Related]
5. Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1. Basso D; Bozzato D; Padoan A; Moz S; Zambon CF; Fogar P; Greco E; Scorzeto M; Simonato F; Navaglia F; Fassan M; Pelloso M; Dupont S; Pedrazzoli S; Fassina A; Plebani M Cell Commun Signal; 2014 Mar; 12():20. PubMed ID: 24670043 [TBL] [Abstract][Full Text] [Related]
6. Intracellular expression of inflammatory proteins S100A8 and S100A9 leads to epithelial-mesenchymal transition and attenuated aggressivity of breast cancer cells. Cormier K; Harquail J; Ouellette RJ; Tessier PA; Guerrette R; Robichaud GA Anticancer Agents Med Chem; 2014 Jan; 14(1):35-45. PubMed ID: 24041228 [TBL] [Abstract][Full Text] [Related]
7. Robust shifts in S100a9 expression with aging: a novel mechanism for chronic inflammation. Swindell WR; Johnston A; Xing X; Little A; Robichaud P; Voorhees JJ; Fisher G; Gudjonsson JE Sci Rep; 2013; 3():1215. PubMed ID: 23386971 [TBL] [Abstract][Full Text] [Related]
8. S100A8 promotes epithelial-mesenchymal transition and metastasis under TGF-β/USF2 axis in colorectal cancer. Li S; Zhang J; Qian S; Wu X; Sun L; Ling T; Jin Y; Li W; Sun L; Lai M; Xu F Cancer Commun (Lond); 2021 Feb; 41(2):154-170. PubMed ID: 33389821 [TBL] [Abstract][Full Text] [Related]
9. Elevated serum levels of calcium-binding S100 proteins A8 and A9 reflect disease activity and abnormal differentiation of keratinocytes in psoriasis. Benoit S; Toksoy A; Ahlmann M; Schmidt M; Sunderkötter C; Foell D; Pasparakis M; Roth J; Goebeler M Br J Dermatol; 2006 Jul; 155(1):62-6. PubMed ID: 16792753 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of S100A8/A9 ameliorates renal interstitial fibrosis in diabetic nephropathy. Du L; Chen Y; Shi J; Yu X; Zhou J; Wang X; Xu L; Liu J; Gao J; Gu X; Wang T; Yin Z; Li C; Yan M; Wang J; Yin X; Lu Q Metabolism; 2023 Jul; 144():155376. PubMed ID: 36521551 [TBL] [Abstract][Full Text] [Related]
11. Interleukin 17 Promotes Expression of Alarmins S100A8 and S100A9 During the Inflammatory Response of Keratinocytes. Christmann C; Zenker S; Martens L; Hübner J; Loser K; Vogl T; Roth J Front Immunol; 2020; 11():599947. PubMed ID: 33643287 [TBL] [Abstract][Full Text] [Related]
12. S100A8/A9, a key mediator for positive feedback growth stimulation of normal human keratinocytes. Nukui T; Ehama R; Sakaguchi M; Sonegawa H; Katagiri C; Hibino T; Huh NH J Cell Biochem; 2008 May; 104(2):453-64. PubMed ID: 18044712 [TBL] [Abstract][Full Text] [Related]
13. DAMP molecules S100A9 and S100A8 activated by IL-17A and house-dust mites are increased in atopic dermatitis. Jin S; Park CO; Shin JU; Noh JY; Lee YS; Lee NR; Kim HR; Noh S; Lee Y; Lee JH; Lee KH Exp Dermatol; 2014 Dec; 23(12):938-41. PubMed ID: 25308296 [TBL] [Abstract][Full Text] [Related]
14. S100A8/A9 promotes parenchymal damage and renal fibrosis in obstructive nephropathy. Tammaro A; Florquin S; Brok M; Claessen N; Butter LM; Teske GJD; de Boer OJ; Vogl T; Leemans JC; Dessing MC Clin Exp Immunol; 2018 Sep; 193(3):361-375. PubMed ID: 29746703 [TBL] [Abstract][Full Text] [Related]
15. RAGE-binding S100A8/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelial-mesenchymal transition. Yin C; Li H; Zhang B; Liu Y; Lu G; Lu S; Sun L; Qi Y; Li X; Chen W Breast Cancer Res Treat; 2013 Nov; 142(2):297-309. PubMed ID: 24177755 [TBL] [Abstract][Full Text] [Related]
16. The expression of S100A8/S100A9 is inducible and regulated by the Hippo/YAP pathway in squamous cell carcinomas. Li Y; Kong F; Jin C; Hu E; Shao Q; Liu J; He D; Xiao X BMC Cancer; 2019 Jun; 19(1):597. PubMed ID: 31208368 [TBL] [Abstract][Full Text] [Related]
17. S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells. Hermani A; De Servi B; Medunjanin S; Tessier PA; Mayer D Exp Cell Res; 2006 Jan; 312(2):184-97. PubMed ID: 16297907 [TBL] [Abstract][Full Text] [Related]
18. S100A8 and S100A9 Are Important for Postnatal Development of Gut Microbiota and Immune System in Mice and Infants. Willers M; Ulas T; Völlger L; Vogl T; Heinemann AS; Pirr S; Pagel J; Fehlhaber B; Halle O; Schöning J; Schreek S; Löber U; Essex M; Hombach P; Graspeuntner S; Basic M; Bleich A; Cloppenborg-Schmidt K; Künzel S; Jonigk D; Rupp J; Hansen G; Förster R; Baines JF; Härtel C; Schultze JL; Forslund SK; Roth J; Viemann D Gastroenterology; 2020 Dec; 159(6):2130-2145.e5. PubMed ID: 32805279 [TBL] [Abstract][Full Text] [Related]
19. Melanoma cell adhesion molecule is the driving force behind the dissemination of melanoma upon S100A8/A9 binding in the original skin lesion. Chen Y; Sumardika IW; Tomonobu N; Winarsa Ruma IM; Kinoshita R; Kondo E; Inoue Y; Sato H; Yamauchi A; Murata H; Yamamoto KI; Tomida S; Shien K; Yamamoto H; Soh J; Liu M; Futami J; Sasai K; Katayama H; Kubo M; Putranto EW; Hibino T; Sun B; Nishibori M; Toyooka S; Sakaguchi M Cancer Lett; 2019 Jun; 452():178-190. PubMed ID: 30904617 [TBL] [Abstract][Full Text] [Related]